KAG-308, a newly-identified EP4-selective agonist shows...

KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration

Watanabe, Yusuke, Murata, Takahiko, Amakawa, Masahiro, Miyake, Yoshihide, Handa, Tango, Konishi, Katsuhiko, Matsumura, Yasushi, Tanaka, Takuji, Takeuchi, Koji
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
754
Language:
english
Journal:
European Journal of Pharmacology
DOI:
10.1016/j.ejphar.2015.02.021
Date:
May, 2015
File:
PDF, 7.19 MB
english, 2015
Conversion to is in progress
Conversion to is failed